![Government panel likely to decide on Covovax as a heterologous booster dose for adults on January 11](https://th-i.thgim.com/public/incoming/u1ip8m/article66360597.ece/alternates/LANDSCAPE_1200/09_Vaccine_Dose_07_01_Delhi.jpg)
Government panel likely to decide on Covovax as a heterologous booster dose for adults on January 11
The Hindu
The Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) is scheduled to meet on January 11
An expert panel of the central drugs regulatory authority is likely to take a decision on Wednesday on granting market authorisation to SII's COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said.
The Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) is scheduled to meet on January 11.
Explained | Corbevax and Covovax: How are they different from other COVID-19 vaccines?
Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII), had written a letter to the the Drugs Controller General of India (DCGI) recently for the approval to Covovax as a heterologous booster dose for adults in view of the escalating pandemic situation in some countries, an official source told.
The DCGI had approved Covovax for restricted use in emergency situations for adults on December 28, 2021, for those in the 12-17 age group on March 9, 2022, and also in children aged 7- 11 years on June 28, 2022, subject to certain conditions.
Covovax is manufactured by the SII through technology transfer from Novavax.
It has been approved by the European Medicines Agency for conditional marketing authorisation.
![](/newspic/picid-1269750-20240611100854.jpg)
The Madras High Court on Tuesday, June 11, 2024, permitted Anna University to deposit, in three monthly instalments, an amount of ₹73.23 lakh before the Central Government Industrial Tribunal (CGIT) as a condition to hear a statutory appeal preferred by the varsity against the Coimbatore Regional Provident Fund (RPF) Commissioner’s order to pay dues to the tune of ₹2.44 crore to contract employees.